.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M05B_DrugsAffectingBoneStructureAndMineralization.M05BB07_RisedronicAcidAndColecal.RisedronicAcidAndColecal .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M05B_DrugsAffectingBoneStructureAndMineralization.M05BB07_RisedronicAcidAndColecal.RisedronicAcidAndColecal| name: | RisedronicAcidAndColecalciferol | |
| ATC code: | M05BB07 | route: | oral |
| compartments: | 1 | |
| dosage: | 35 | mg |
| volume of distribution: | 13 | L |
| clearance: | 90 | mL/min |
| other parameters in model implementation | ||
Combination product of risedronic acid (a bisphosphonate for osteoporosis and bone diseases) and colecalciferol (vitamin D3, used to enhance calcium absorption and bone health). This fixed-dose combination is approved in some countries for prevention and treatment of osteoporosis in patients at risk of vitamin D deficiency.
Pharmacokinetic parameters for the fixed combination in adults; estimates based on individual components due to lack of direct published population PK data on the combination.